Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic

被引:171
作者
El-Shabasy, Rehan M. [1 ]
Nayel, Mohamed A. [2 ]
Taher, Mohamed M. [3 ]
Abdelmonem, Rehab [4 ]
Shoueir, Kamel R. [5 ,6 ]
Kenawy, El Rafaie [7 ]
机构
[1] Menoufia Univ, Dept Chem, Fac Sci, Shibin Al Kawm 32512, Egypt
[2] Univ Sadat City, Fac Vet Med, Dept Anim Med & Infect Dis, Menoufia 32897, Egypt
[3] Cairo Univ, Dept Chem, Fac Sci, Giza 12613, Egypt
[4] Misr Univ Sci & Technol, Fac Pharm, Dept Ind Pharm, 6th October, Egypt
[5] Kafrelsheikh Univ, Inst Nanosci & Nanotechnol, Kafrelsheikh 33516, Egypt
[6] Univ Strasbourg, CNRS, UMR 7515, Inst Chim & Procedes Energie Environ & Sante ICPE, 25 Rue Becquerel, F-67087 Strasbourg, France
[7] Tanta Univ, Fac Sci, Chem Dept, Polymer Res Grp, Tanta, Egypt
关键词
COVID-19; SARS-COV-2; Mutation; New variant strain; Vaccine; Reinfection; NCOV-19; AZD1222; VACCINE; UNITED-STATES; 3RD WAVE; EFFICACY; ANTIBODY; B.1.1.7; TIME; 1ST;
D O I
10.1016/j.ijbiomac.2022.01.118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been more than one year since the first case of the coronaviruses was infected by COVID-19 in China. The world witnessed three waves of the corona virus till now, and more upcoming is expected, whereas several challenges are presented. Empirical data displayed that the features of the virus effects do vary between the three periods. The severity of the disease, differences in symptoms, attitudes of the people have been reported, although the comparative characteristics of the three waves still keep essentially indefinite. In contrast, the sense of danger toward the cries gradually decreases in most countries. This may be due to some factors, including the approved vaccines, introducing alternative plans from politicians to control and deal with the epidemic, and decreasing the mortality rates. However, the alarm voice started to rise again with the appearance of new variant strains with several mutations in the virus. Several more questions began to be asked without sufficient answers. Mutations in COVID-19 have introduced an extreme challenge in preventing and treating SARS-COV-2. The essential feature for mutations is producing new variants known by high tensmibility, disturbing the viral fitness, and enhancing the virus replication. One of the variants that has emerged recently is the Delta variant (B.1.617.2), which was firstly detected in India. In November 2021, a more ferocious mutant appeared in South Africa, also called omicron (B.1.1.529). These mutants grabbed world attention because of their higher transmissibility than the progenitor variants and spread rapidly. Several information about the virus are still confusing and remains secret. There are eight approved vaccines in the market; however, the investigation race about their effect against reinfection and their role against the new variants is still under investigation. Furthermore, this is the first time vaccinating against COVID-19, so the question remains: Will we need an annual dose of the corona vaccines, and the side effects don't been observed till now?
引用
收藏
页码:161 / 168
页数:8
相关论文
共 76 条
[1]   SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses [J].
Agerer, Benedikt ;
Koblischke, Maximilian ;
Gudipati, Venugopal ;
Montano-Gutierrez, Luis Fernando ;
Smyth, Mark ;
Popa, Alexandra ;
Genger, Jakob-Wendelin ;
Endler, Lukas ;
Florian, David M. ;
Muehlgrabner, Vanessa ;
Graninger, Marianne ;
Aberle, Stephan W. ;
Husa, Anna-Maria ;
Shaw, Lisa Ellen ;
Lercher, Alexander ;
Gattinger, Pia ;
Torralba-Gombau, Ricard ;
Trapin, Doris ;
Penz, Thomas ;
Barreca, Daniele ;
Fae, Ingrid ;
Wenda, Sabine ;
Traugott, Marianna ;
Walder, Gernot ;
Pickl, Winfried F. ;
Thiel, Volker ;
Allerberger, Franz ;
Stockinger, Hannes ;
Puchhammer-Stoeckl, Elisabeth ;
Weninger, Wolfgang ;
Fischer, Gottfried ;
Hoepler, Wolfgang ;
Pawelka, Erich ;
Zoufaly, Alexander ;
Valenta, Rudolf ;
Bock, Christoph ;
Paster, Wolfgang ;
Geyeregger, Rene ;
Farlik, Matthias ;
Halbritter, Florian ;
Huppa, Johannes B. ;
Aberle, Judith H. ;
Bergthaler, Andreas .
SCIENCE IMMUNOLOGY, 2021, 6 (57)
[3]  
[Anonymous], 2021, Classification of Omicron. (B.1.1.529): SARS-CoV-2 variant of concern
[4]  
[Anonymous], 2021, HEAVILY MUTATED OMIC
[5]  
[Anonymous], ONE MINUTE SUMMARY P, P1
[6]  
[Anonymous], 2021, EXPLAINED WHAT WE KN
[7]  
Aouissi H.A., 2021, ALGERIAS PREPAREDNES, DOI [10.35772/ghm.2021.01117, DOI 10.35772/GHM.2021.01117]
[8]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[9]   The 'third wave': impending cognitive and functional decline in COVID-19 survivors [J].
Baker, Hanan A. ;
Safavynia, Seyed A. ;
Evered, Lisbeth A. .
BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (01) :44-47
[10]   Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective [J].
Baumgart, Matthew ;
Snyder, Heather M. ;
Carrillo, Maria C. ;
Fazio, Sam ;
Kim, Hye ;
Johns, Harry .
ALZHEIMERS & DEMENTIA, 2015, 11 (06) :718-726